GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Well Lead Medical Co Ltd (SHSE:603309) » Definitions » Cyclically Adjusted Revenue per Share

Well Lead Medical Co (SHSE:603309) Cyclically Adjusted Revenue per Share : ¥3.74 (As of Mar. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Well Lead Medical Co Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Well Lead Medical Co's adjusted revenue per share for the three months ended in Mar. 2024 was ¥1.046. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ¥3.74 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Well Lead Medical Co's average Cyclically Adjusted Revenue Growth Rate was 3.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2024-04-29), Well Lead Medical Co's current stock price is ¥12.35. Well Lead Medical Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was ¥3.74. Well Lead Medical Co's Cyclically Adjusted PS Ratio of today is 3.30.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Well Lead Medical Co was 5.39. The lowest was 2.78. And the median was 3.82.


Well Lead Medical Co Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Well Lead Medical Co's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Well Lead Medical Co Cyclically Adjusted Revenue per Share Chart

Well Lead Medical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 3.69

Well Lead Medical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.62 3.61 3.65 3.69 3.74

Competitive Comparison of Well Lead Medical Co's Cyclically Adjusted Revenue per Share

For the Medical Instruments & Supplies subindustry, Well Lead Medical Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Well Lead Medical Co's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Well Lead Medical Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Well Lead Medical Co's Cyclically Adjusted PS Ratio falls into.



Well Lead Medical Co Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Well Lead Medical Co's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=1.046/114.6694*114.6694
=1.046

Current CPI (Mar. 2024) = 114.6694.

Well Lead Medical Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 0.755 98.200 0.882
201409 1.221 98.900 1.416
201412 0.725 99.000 0.840
201503 0.436 99.900 0.500
201506 0.599 99.500 0.690
201509 0.587 100.500 0.670
201512 0.686 100.600 0.782
201603 0.382 102.200 0.429
201606 0.514 101.400 0.581
201609 0.546 102.400 0.611
201612 0.615 102.600 0.687
201703 0.421 103.200 0.468
201706 0.715 103.100 0.795
201709 0.582 104.100 0.641
201712 0.692 104.500 0.759
201803 0.486 105.300 0.529
201806 0.776 104.900 0.848
201809 0.669 106.600 0.720
201812 1.000 106.500 1.077
201903 0.754 107.700 0.803
201906 1.021 107.700 1.087
201909 1.022 109.800 1.067
201912 1.136 111.200 1.171
202003 0.593 112.300 0.606
202006 1.501 110.400 1.559
202009 1.104 111.700 1.133
202012 1.099 111.500 1.130
202103 0.872 112.662 0.888
202106 0.956 111.769 0.981
202109 1.065 112.215 1.088
202112 1.450 113.108 1.470
202203 1.013 114.335 1.016
202206 1.132 114.558 1.133
202209 1.292 115.339 1.285
202212 1.232 115.116 1.227
202303 1.249 115.116 1.244
202306 0.953 114.558 0.954
202309 1.133 115.339 1.126
202312 1.439 114.669 1.439
202403 1.046 114.669 1.046

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Well Lead Medical Co  (SHSE:603309) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Well Lead Medical Co's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=12.35/3.74
=3.30

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Well Lead Medical Co was 5.39. The lowest was 2.78. And the median was 3.82.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Well Lead Medical Co Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Well Lead Medical Co's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Well Lead Medical Co (SHSE:603309) Business Description

Traded in Other Exchanges
N/A
Address
No. 45-47, South of Guomao Avenue, No. 4, Area C, Jinhu Industrial City, Hualong Town, Panyu District, Guangdong Province, Guangzhou City, CHN, 511434
Well Lead Medical Co Ltd is engaged in research, production, and sales of medical catheters in anaesthesia, urology, respiratory and hemodialysis region. Its products include Endotracheal Tube, Standar Endotracheal Tube, and Suction Endotracheal Tube. The company products are used in surgery, treatment, first aid, and nursing. The company exports its products to North America, Europe, and Japan.

Well Lead Medical Co (SHSE:603309) Headlines

No Headlines